New study changes view about the genetics of leukemia risk

by Bill Hathaway
New study changes view about the genetics of leukemia risk
Credit: Shutterstock

(Medical Xpress)—A gene that helps keep blood free of cancer is controlled by tiny pieces of RNA, a finding that may lead to better ways to diagnose blood cancers and even lead to new forms of treatment, Yale School of Medicine researchers report online Oct. 10 in the journal Cell Reports.

In the past few years researchers have identified the crucial role of the gene TET2 in keeping healthy. Mutations of the gene have been found in about 20% of leukemias and indicate a poor prognosis for patients. However, the gene was thought to be irrelevant in 80% of leukemia cases.

The new study changes this view. The researchers identified the agents that could be responsible for many leukemias without TET2 mutation—a host of microRNAs from the large expanse of DNA that do not code for proteins. They found that patients with large numbers of these microRNAs are more likely to have impaired TET2 function, even without a known mutation, and are thus likely to have aggressive forms of cancer.

This knowledge could help doctors develop a course of treatment for leukemia patients, said Jun Lu, assistant professor of genetics, researcher in the Yale Stem Cell Center and Yale Cancer Center, and senior author of the paper.

Lu points out that half of leukemia patients who lack these markers may be spared side effects of aggressive treatments.

"If these markers are absent and TET2 gene is not mutated, then the 50% of leukemia patients without this marker would be spared harsher treatment such as high-dose chemotherapy or bone marrow transplants," Lu said.

New therapies that could block these microRNAs could in theory help treat , he said.

"However, there is currently no good way to do that, but it is a problem I am very hopeful will be resolved," Lu said.

add to favorites email to friend print save as pdf

Related Stories

Leukemia cells are addicted to a healthy gene

Sep 30, 2013

What keeps leukemia cells alive almost forever, able to continue dividing endlessly and aggressively? New research at the Weizmann Institute suggests that, in around a quarter of all leukemias, the cancer ...

Recommended for you

US women's awareness of breast density varies

12 hours ago

Disparities in the level of awareness and knowledge of breast density exist among U.S. women, according to the results of a Mayo Clinic study published in the Journal of Clinical Oncology.

Study shows why some brain cancers resist treatment

12 hours ago

Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide.

Researchers identify genes responsible for lung tumors

14 hours ago

The lung transcription factor Nkx2-1 is an important gene regulating lung formation and normal respiratory functions after birth. Alterations in the expression of this transcription factor can lead to diseases such as lung ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.